Matches in SemOpenAlex for { <https://semopenalex.org/work/W228938400> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W228938400 endingPage "7" @default.
- W228938400 startingPage "41" @default.
- W228938400 abstract "To analyse data on patients who developed catastrophic antiphospholipid syndrome (CAPS) in primary and secondary APS, to assess outcomes of CAPS.We analysed retrospectively the data on 164 patients with systemic lupus erythematosus (SLE) and APS, on 76 patients with primary APS (PAPS) treated in the Institute of Rheumatology from 1989. Verification of vascular complications was made using ultrasonic dopplerography (UDG) of peripheral vessels, echocardiography of the heart, CT of the brain, abdominal organs. Anticardiolipin antibodies (ACLab) and lupus anticoagulant (LA) served as serological markers of APS.In the observation period of 9.4 +/- 4.2 years, 33 patients (23 females and 10 males) out of 164 patients with SLE+APS developed CAPS, 8 of them survived while 25 died. CAPS patients had no differences by age, duration of the disease, its activity and symptoms from patients who had no CAPS. Ten out of 76 patients with PAPS developed CAPS, 7 of them died. The analysis of the concomitant factors which may initiate PAPS showed that in SLE and APS these factors consisted of initial menopause (n = 2), infection (n = 12), including pneumonia (n = 7), acute respiratory disease (n = 3), food poisoning (n = 1), abscess (n = 1). Cancer was in one patient, trauma after road accident in one patient. Trigger factor was not determined in 13 patients. In PAPS provoking factors were pneumonia (n = 2) and abscess (n = 1), in 7 patients these factors were not detected.Any infection in SLE patients should be adequately treated with antibiotics; APS patients treated surgically should receive parenteral anticoagulants instead of oral ones; puerperas with APS must receive adequate parenteral anticoagulant therapy for at least 6 weeks; in exacerbation of SLE, APS patients should receive parenteral anticoagulants with following hypocoagulation with oral anticoagulants." @default.
- W228938400 created "2016-06-24" @default.
- W228938400 creator A5025860530 @default.
- W228938400 creator A5061975855 @default.
- W228938400 creator A5062371608 @default.
- W228938400 creator A5085679639 @default.
- W228938400 date "2005-01-01" @default.
- W228938400 modified "2023-09-27" @default.
- W228938400 title "[Catastrophic antiphospholipid syndrome: diagnosis and treatment]." @default.
- W228938400 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15989002" @default.
- W228938400 hasPublicationYear "2005" @default.
- W228938400 type Work @default.
- W228938400 sameAs 228938400 @default.
- W228938400 citedByCount "0" @default.
- W228938400 crossrefType "journal-article" @default.
- W228938400 hasAuthorship W228938400A5025860530 @default.
- W228938400 hasAuthorship W228938400A5061975855 @default.
- W228938400 hasAuthorship W228938400A5062371608 @default.
- W228938400 hasAuthorship W228938400A5085679639 @default.
- W228938400 hasConcept C126322002 @default.
- W228938400 hasConcept C141071460 @default.
- W228938400 hasConcept C159654299 @default.
- W228938400 hasConcept C198451711 @default.
- W228938400 hasConcept C203014093 @default.
- W228938400 hasConcept C2776874634 @default.
- W228938400 hasConcept C2777247642 @default.
- W228938400 hasConcept C2777914695 @default.
- W228938400 hasConcept C2779384505 @default.
- W228938400 hasConcept C2780022809 @default.
- W228938400 hasConcept C2780868729 @default.
- W228938400 hasConcept C45189115 @default.
- W228938400 hasConcept C71924100 @default.
- W228938400 hasConcept C90924648 @default.
- W228938400 hasConceptScore W228938400C126322002 @default.
- W228938400 hasConceptScore W228938400C141071460 @default.
- W228938400 hasConceptScore W228938400C159654299 @default.
- W228938400 hasConceptScore W228938400C198451711 @default.
- W228938400 hasConceptScore W228938400C203014093 @default.
- W228938400 hasConceptScore W228938400C2776874634 @default.
- W228938400 hasConceptScore W228938400C2777247642 @default.
- W228938400 hasConceptScore W228938400C2777914695 @default.
- W228938400 hasConceptScore W228938400C2779384505 @default.
- W228938400 hasConceptScore W228938400C2780022809 @default.
- W228938400 hasConceptScore W228938400C2780868729 @default.
- W228938400 hasConceptScore W228938400C45189115 @default.
- W228938400 hasConceptScore W228938400C71924100 @default.
- W228938400 hasConceptScore W228938400C90924648 @default.
- W228938400 hasIssue "5" @default.
- W228938400 hasLocation W2289384001 @default.
- W228938400 hasOpenAccess W228938400 @default.
- W228938400 hasPrimaryLocation W2289384001 @default.
- W228938400 hasRelatedWork W186721554 @default.
- W228938400 hasRelatedWork W2032162517 @default.
- W228938400 hasRelatedWork W2054281925 @default.
- W228938400 hasRelatedWork W2068310703 @default.
- W228938400 hasRelatedWork W2132103149 @default.
- W228938400 hasRelatedWork W2181383775 @default.
- W228938400 hasRelatedWork W2312550137 @default.
- W228938400 hasRelatedWork W2376019609 @default.
- W228938400 hasRelatedWork W2982038516 @default.
- W228938400 hasRelatedWork W4239987606 @default.
- W228938400 hasVolume "77" @default.
- W228938400 isParatext "false" @default.
- W228938400 isRetracted "false" @default.
- W228938400 magId "228938400" @default.
- W228938400 workType "article" @default.